CORDIS · 316088 · FP7
SERBORDISINN Strengthening the Research Potential of IMGGE through Reinforcement of Biomedical Science of Rare Diseases in Serbia – en route for innovation
Coordinator: INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS)
SERBORDISinn will enable IMGGE to become the most recognizable molecular genetic (MG) centre in the Balkans. IMGGE is the leading Serbian MG research institution, employing scientists with the highest expertise in molecular biology and molecular genetics. Research in the field of biomedical science of rare diseases (RD) is a major interest of IMGGE’s Laboratory for Molecular Hematology, Laboratory for Molecular Biology, Laboratory for Human Molecular Genetics and Laboratory for Molecular Genetics of Industrial Microorganisms. EU partnering organizations and EU experts, well known for their ex…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
Co-funding: the European Union contributes €2.0M toward a total project budget of €2.2M — a funding rate of 90%, with the remainder covered by the consortium partners. The project runs over approximately 3 years from 2013-07-01 to 2016-06-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from RS
see all →- CROSS-REIS — CROSS-disciplinary network for research excellence in Regenerative Economy Innovation eco-Systems101136834 · HORIZON · €4.4M
- EINSTEIN — EXCELLENCE INITIATIVE FOR NUTRIFOOD-BASED THERANOSTICS FOR HEALTHY EUROPEAN SOCIETY101136377 · HORIZON · €3.9M
- SENSEIVER — Low-cost and energy-efficient LTCC sensor/IR-UWB transceiver solutions for sustainable healthy environment289481 · FP7 · €3.0M
- INNOSENSE — Reinforcement of BioSense Center – ICT for Sustainability and Eco-Innovation316191 · FP7 · €2.6M
- HEROMAT — PROTECTION OF CULTURAL HERITAGE OBJECTS WITH MULTIFUNCTIONAL ADVANCED MATERIALS282992 · FP7 · €2.6M
- HIP-2D-QM — HIDDEN PHASES IN 2D-QUANTUM MATERIALS101185375 · HORIZON · €2.5M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CSA-SA funding scheme.
- What is the EU contribution?
- The European Commission contributes €2.0M toward a total project budget of €2.2M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS).
- What is the project timeline?
- The project runs from 2013-07-01 to 2016-06-30 — approximately 3 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 316088.